NCT05324449View on ClinicalTrials.gov

Epidiolex® for Anxiety in Pediatric Epilepsy

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

March 17, 2025

Study Completion Date

May 5, 2025

Conditions

AnxietyEpilepsy

Interventions

DRUG

Cannabidiol 100 MG/ML

pharmaceutical grade cannabidiol

Trial Locations (1)

21205

Kennedy Krieger Institute, Baltimore

All Listed Sponsors

lead

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER